DE69411584T2 - Isoxazoline derivate anwendbar als fibrinogen rezeptor antagonisten - Google Patents
Isoxazoline derivate anwendbar als fibrinogen rezeptor antagonistenInfo
- Publication number
- DE69411584T2 DE69411584T2 DE69411584T DE69411584T DE69411584T2 DE 69411584 T2 DE69411584 T2 DE 69411584T2 DE 69411584 T DE69411584 T DE 69411584T DE 69411584 T DE69411584 T DE 69411584T DE 69411584 T2 DE69411584 T2 DE 69411584T2
- Authority
- DE
- Germany
- Prior art keywords
- fibrinogen receptor
- receptor antagonists
- compounds
- isoxazoline derivatives
- derivatives applicable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15785193A | 1993-11-24 | 1993-11-24 | |
US08/304,614 US5446056A (en) | 1993-11-24 | 1994-09-12 | Isoxazoline compounds useful as fibrinogen receptor antagonists |
PCT/US1994/013153 WO1995014682A1 (en) | 1993-11-24 | 1994-11-14 | Isoxazoline compounds useful as fibrinogen receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69411584D1 DE69411584D1 (de) | 1998-08-13 |
DE69411584T2 true DE69411584T2 (de) | 1998-12-17 |
Family
ID=26854532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69411584T Expired - Fee Related DE69411584T2 (de) | 1993-11-24 | 1994-11-14 | Isoxazoline derivate anwendbar als fibrinogen rezeptor antagonisten |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0730589B1 (de) |
JP (1) | JPH09505589A (de) |
AT (1) | ATE168106T1 (de) |
AU (1) | AU677481B2 (de) |
CA (1) | CA2174415A1 (de) |
DE (1) | DE69411584T2 (de) |
DK (1) | DK0730589T3 (de) |
ES (1) | ES2120713T3 (de) |
NZ (1) | NZ276631A (de) |
WO (1) | WO1995014682A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
IL118007A0 (en) * | 1995-05-24 | 1996-08-04 | Du Pont Merck Pharma | Isoxazoline compounds pharmaceutical compositions containing them and their use |
EP0874629B1 (de) * | 1995-12-21 | 2004-05-19 | Bristol-Myers Squibb Pharma Company | ISOXAZOLIN, ISOTHIAZOLIN UND PYRAZOLIN ALS FAKTOR Xa INHIBITOREN |
US5939418A (en) * | 1995-12-21 | 1999-08-17 | The Dupont Merck Pharmaceutical Company | Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors |
ZA972195B (en) * | 1996-03-15 | 1998-09-14 | Du Pont Merck Pharma | Spirocycle integrin inhibitors |
EP0888344A1 (de) * | 1996-03-15 | 1999-01-07 | The Du Pont Merck Pharmaceutical Company | Spirocycle als integrin inhibitoren |
CA2263311A1 (en) * | 1996-08-15 | 1998-02-19 | Pasquale Nicholas Confalone | Cyclic carbamates and isoxazolidines as iib/iiia antagonists |
EP0934305A4 (de) * | 1996-08-29 | 2001-04-11 | Merck & Co Inc | Integrinantagonisten |
US6214834B1 (en) | 1997-03-28 | 2001-04-10 | Dupont Pharmaceuticals Company | Integrin inhibitor prodrugs |
US7109326B2 (en) | 1997-04-15 | 2006-09-19 | Genentech, Inc. | Halo-alkoxycarbonyl prodrugs |
US5998424A (en) | 1997-06-19 | 1999-12-07 | Dupont Pharmaceuticals Company | Inhibitors of factor Xa with a neutral P1 specificity group |
ES2239806T3 (es) | 1997-06-19 | 2005-10-01 | Bristol-Myers Squibb Pharma Company | Inhibidores del factor xa con un grupo de especificidad neutro p1. |
ZA988735B (en) | 1997-10-06 | 2000-03-23 | Du Pont Pharm Co | An efficient method for the conversion of nitriles to amidines. |
JP2002509924A (ja) | 1998-03-27 | 2002-04-02 | デュポン ファーマシューティカルズ カンパニー | 第Xa因子阻害剤としてのジ置換ピラゾリン類およびトリアゾリン類 |
EP1091945A1 (de) | 1998-06-29 | 2001-04-18 | Du Pont Pharmaceuticals Company | Zyklische carbamate und isoxazolidine als iib/iiia antagonisten |
US6319937B1 (en) | 1998-11-18 | 2001-11-20 | Dupont Pharmaceuticals Company | Isoxazoline fibrinogen receptor antagonists |
US6303609B1 (en) | 1998-11-18 | 2001-10-16 | Dupont Pharmaceuticals Company | Isoxazoline fibrinogen receptor antagonists |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99537A (en) * | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US5239113A (en) * | 1991-10-15 | 1993-08-24 | Monsanto Company | Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof |
-
1994
- 1994-11-14 AT AT95901913T patent/ATE168106T1/de not_active IP Right Cessation
- 1994-11-14 WO PCT/US1994/013153 patent/WO1995014682A1/en active IP Right Grant
- 1994-11-14 CA CA002174415A patent/CA2174415A1/en not_active Abandoned
- 1994-11-14 ES ES95901913T patent/ES2120713T3/es not_active Expired - Lifetime
- 1994-11-14 AU AU10978/95A patent/AU677481B2/en not_active Ceased
- 1994-11-14 DK DK95901913T patent/DK0730589T3/da active
- 1994-11-14 NZ NZ276631A patent/NZ276631A/en unknown
- 1994-11-14 DE DE69411584T patent/DE69411584T2/de not_active Expired - Fee Related
- 1994-11-14 EP EP95901913A patent/EP0730589B1/de not_active Expired - Lifetime
- 1994-11-14 JP JP7515116A patent/JPH09505589A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
ES2120713T3 (es) | 1998-11-01 |
CA2174415A1 (en) | 1995-06-01 |
AU677481B2 (en) | 1997-04-24 |
ATE168106T1 (de) | 1998-07-15 |
DK0730589T3 (da) | 1999-02-01 |
NZ276631A (en) | 1997-06-24 |
WO1995014682A1 (en) | 1995-06-01 |
AU1097895A (en) | 1995-06-13 |
JPH09505589A (ja) | 1997-06-03 |
EP0730589B1 (de) | 1998-07-08 |
EP0730589A1 (de) | 1996-09-11 |
DE69411584D1 (de) | 1998-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69426604D1 (de) | Isoxazoline und isoxazole derivate als fibrinogen rezeptor antagonisten | |
PL323835A1 (en) | Novel isoxazolinic and isoxazolic antagonists of fibrinogen receptor | |
DE69411584D1 (de) | Isoxazoline derivate anwendbar als fibrinogen rezeptor antagonisten | |
ATE178614T1 (de) | Zyklische verbindungen zur verwendung als inhibitoren des glycoprotein iib/iiia | |
TR199700999T1 (xx) | Askomisinler. | |
WO2005035495A3 (en) | Fibrinogen receptor antagonists and their use | |
WO2000029406A3 (en) | Novel isoxazoline fibrinogen receptor antagonists | |
ATE187956T1 (de) | Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel | |
MX9709081A (es) | Nuevos antagonistas del receptor fibrinogeno de isoxazolina e isoxazol. | |
NO933558L (no) | Benzimidazoler, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
DE69810332D1 (de) | Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: DU PONT PHARMACEUTICALS CO., WILMINGTON, DEL., US |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: BRISTOL-MYERS SQUIBB PHARMA CO., PRINCETON, N.J., |
|
8339 | Ceased/non-payment of the annual fee |